Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

BVS holding history

Bioventus Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BVS overviewAll 13F holders of BVSFull Q2 2026 holdings

Shares (Q2 2026)
69,683
Value
$657.8K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of BVS by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202669,683$657.8K<0.1%+5,787+9.1%AddedHolders
Q1 202663,896$583.4K<0.1%−17,769−21.8%ReducedHolders
Q4 202581,665$607.6K<0.1%+9,705+13.5%AddedHolders
Q3 202571,960$481.4K<0.1%−15,653−17.9%ReducedHolders
Q2 202587,613$580.0K<0.1%+41,441+89.8%AddedHolders
Q1 202546,172$422.5K<0.1%+7,682+20.0%AddedHolders
Q4 202438,490$404.1K<0.1%+4,114+12.0%AddedHolders
Q3 202434,376$410.8K<0.1%+21,600+169.1%AddedHolders
Q2 202412,776$73.5K<0.1%+11,471+879.0%AddedHolders
Q1 20241,305$6.79K<0.1%−1,071−45.1%ReducedHolders
Q4 20232,376$12.5K<0.1%−1,902−44.5%ReducedHolders
Q3 20234,278$14.1K<0.1%+2,469+136.5%AddedHolders
Q2 20231,809$5.23K<0.1%−13,918−88.5%ReducedHolders
Q1 202315,727$16.8K<0.1%+2,983+23.4%AddedHolders
Q4 202212,744$33.3K<0.1%+5,372+72.9%AddedHolders
Q3 20227,372$51.0K<0.1%+3,462+88.5%AddedHolders
Q2 20223,910$27.0K<0.1%−1,198−23.5%ReducedHolders
Q1 20225,108$72.0K<0.1%−8,485−62.4%ReducedHolders
Q4 202113,593$197.0K<0.1%+13,593NewHolders
Q3 20210$00.0%−1,753−100.0%Sold outHolders
Q2 20211,753$31.0K<0.1%−2,535−59.1%ReducedHolders
Q1 20214,288$66.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.